<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00966316</url>
  </required_header>
  <id_info>
    <org_study_id>200707004</org_study_id>
    <nct_id>NCT00966316</nct_id>
  </id_info>
  <brief_title>Establishment and Evaluation to the Effects of a Clinical Pathway for Acute Ischemic Stroke</brief_title>
  <acronym>PAIS</acronym>
  <official_title>Establishment and Evaluation to the Effects of a Clinical Pathway for Acute Ischemic Stroke</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Guangzhou University of Traditional Chinese Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Guangzhou University of Traditional Chinese Medicine</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether the clinical pathway for acute ischemic
      stroke(with combination of traditional Chinese medicine and western medicine) is able to
      improve the outcome of acute ischemic stroke and evaluate its effect on hospital day and
      cost, etc. Meanwhile, the study will discuss the safety and efficiency of this kind of
      Clinical Pathway
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Eligibility Ages Eligible for Study: 18 Years to 85 Years Genders Eligible for Study: Both
      Accepts Healthy Volunteers: No

      Criteria

      Inclusion Criteria:

      Those clinically diagnosed with acute ischemic stroke ； 18-85 years old； Over 6 hours and
      within 14 days from onset 4&lt;=NIHSS &lt;=22; Informed consent signed by patient or his/her family
      ；

      Exclusion Criteria:

      Hemorrhagic stroke; Cerebral hernia; Serious heart, liver, lung, kidney functional
      failure，malignancy; Not cooperative with physician; Psychological disorder; Already taken
      part in other clinical drug trial within the past 3 months
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2009</start_date>
  <completion_date type="Actual">January 2011</completion_date>
  <primary_completion_date type="Actual">August 2010</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>death rate；average hospital day；cost of hospitalization</measure>
    <time_frame>3 months；discharge day</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Modified Rankin Scale (mRS) National Institute of Health Stroke Scale (NIHSS) Barthel Index degree of satisfaction</measure>
    <time_frame>7 day；30 day；3 months</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">314</enrollment>
  <condition>Acute Ischemic Stroke</condition>
  <arm_group>
    <arm_group_label>pathway</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>aspirin，Chinese herbs；acupuncture；rehabilitation；health education；</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>aspirin，chinese herbs；</intervention_name>
    <description>aspirin 300mg/100mg,qd,chinese herbs, one dose ，qd</description>
    <arm_group_label>pathway</arm_group_label>
    <other_name>Bayer</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Ischemic stroke diagnosed with both criteria of traditional Chinese medicine and
             western medicine；

          -  18-85 years old；

          -  Over 6 hours and within 14 days from onset

          -  4&lt;=NIHSS &lt;=22;

          -  Informed consent signed by patient or his/her family ；

        Exclusion Criteria:

          -  Hemorrhagic stroke;

          -  Cerebral hernia;

          -  Serious heart, liver, lung, kidney functional failure,malignancy;

          -  Not cooperative with physician;

          -  Psychological disorder;

          -  Already taken part in other clinical drug trial within the past 3 months
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>yefeng cai, postgraduate</last_name>
    <role>Study Chair</role>
    <affiliation>Guangdong Provincial Hospital of Traditional Chinese Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Guangdong Provincial Hospital of Chinese Medicine</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510120</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <link>
    <url>http://www.gdhtcm.com/</url>
  </link>
  <results_reference>
    <citation>Adams HP Jr, del Zoppo G, Alberts MJ, Bhatt DL, Brass L, Furlan A, Grubb RL, Higashida RT, Jauch EC, Kidwell C, Lyden PD, Morgenstern LB, Qureshi AI, Rosenwasser RH, Scott PA, Wijdicks EF; American Heart Association/American Stroke Association Stroke Council; American Heart Association/American Stroke Association Clinical Cardiology Council; American Heart Association/American Stroke Association Cardiovascular Radiology and Intervention Council; Atherosclerotic Peripheral Vascular Disease Working Group; Quality of Care Outcomes in Research Interdisciplinary Working Group. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Circulation. 2007 May 22;115(20):e478-534. Erratum in: Circulation. 2007 Oct 30;116(18):e515.</citation>
    <PMID>17515473</PMID>
  </results_reference>
  <verification_date>May 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 25, 2009</study_first_submitted>
  <study_first_submitted_qc>August 25, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 26, 2009</study_first_posted>
  <last_update_submitted>May 14, 2011</last_update_submitted>
  <last_update_submitted_qc>May 14, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 17, 2011</last_update_posted>
  <responsible_party>
    <name_title>Yefeng,Cai</name_title>
    <organization>Guangdong Provincial Hospital of Chinese Medicine</organization>
  </responsible_party>
  <keyword>Acute Ischemic Stroke；clinical pathway;TCM；</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Ischemia</mesh_term>
    <mesh_term>Cerebral Infarction</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aspirin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

